Cellarity
Rich Lieberman has accumulated a wealth of experience in the field of scientific research and disease modeling. Rich started as a Postdoctoral Fellow at The University of Connecticut Health Center in 2015 before moving on to become a Scientist at Sanofi Genzyme. Rich then progressed to roles at Fulcrum Therapeutics, including Scientist, Scientist II, Senior Scientist I, and finally Principal Scientist - Disease Modelling Team. Currently, they hold a position as Principal Scientist at Cellarity, showcasing their expertise and dedication to the field.
Rich Lieberman earned a Bachelor of Arts in Psychology and Economics from Assumption University in 2008. Rich continued their education at the University of Hartford, where they obtained a Master of Science in Neuroscience in 2010. Rich then completed their Doctor of Philosophy in Biomedical Science with a focus on Neuroscience at The University of Connecticut Health Center in 2015.
Cellarity
1 followers
Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors. The company’s broad platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them.